Emmanuel Messas
Latest contributions
TAVI - New indications, techniques and devices - Part 2
20 Nov 2023 – From PCR London Valves 2023
Consult this session for a swift overview of evolving TAVI indications and techniques: gain insights into thirty-day outcomes with Evolut FX, stratified by heart team risk, witness the 12-month follow-up of the Valvosoft first-in-man study, uncover sizing considerations in bicuspid tapered aortic valves undergoing TAVI from the...
Innovation fireworks
20 May 2022 – From EuroPCR 2022
Find out more about novel innovative techniques and devices including: Leaflex, a possible alternative to balloon valvuloplasty, Valvosoft, a non-invasive ultrasound therapy or even home blood potassium monitoring!
PCR Valves e-Course 2020 Hotline - ACTIVATION trial, NIUT in patients with severe symptomatic calcific aortic stenosis, CUTTING-EDGE registry...
22 Nov 2020 – From PCR Valves e-Course 2020
- The percutAneous Coronary inTervention prIor to trans-catheter aortic VAlve implantaTION trial. S. Redwood: ACTIVATION Trial. S. Redwood
- Prospective, single-arm clinical investigation for the safety and feasibility study of Valvosoft NIUT in patients with severe symptomatic calcific aortic stenosis - First-in-man. E. Messas
- Outcomes of mitral valve surgery after...
